home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

3rd Annual Formulation & Drug Delivery Congress 2017

 
  December 19, 2016  
     
 
Oxford Global, London, UK
8-9 May 2017


Oxford Global are proud to present our 2017 3rd Annual Formulation & Drug Delivery Congress, taking place on 8 – 9 May 2017 in May in London, UK.

Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will have the opportunity to discuss over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery.

Including 4 interactive streams:

  • Large Molecule Drug Formulation
  • Small Molecule Drug Delivery
  • Small Molecule Drug Formulation
  • Large Molecule Drug Delivery

Download Agenda Now: http://bit.ly/1CBznbr

Free Live Webinar: “API Physical Form Selection”
Hosted by Axel Becker, Senior Scientist, Merck KGaA
Register for Free Today:
http://bit.ly/2gGCHei

Free Webinar Recording
Advances in Small Drugs Formulation Research
Hosted by David Elder, Director, Product Development, GlaxoSmithKline and René Holm, Senior Director, Pharmaceutical Science, H. Lundbeck A/S
Download for Free Today: http://bit.ly/2gZey08

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

 
 
Organized by: Oxford Global
Invited Speakers:

2017 Speakers Include:

 

  • Matthew James Clemente, Chief Technology Officer, Connected Product Systems, Delivery and Device Research & Development, Eli Lilly & Co.
  • Manmohan Singh, Senior Director, Drug Product Development, Takeda Vaccines, Inc.
  •  Advait Badkar, Senior Director, Novel Delivery Technologies, Pfizer, Inc.
  • Geert Mannens, Senior Scientific Director and Fellow, Pharmacokinetics, Dynamics & Metabolism (PDM), Janssen Research & Development
  • Anders Holmen, Senior Director and Head of Pharmaceutical Sciences, AstraZeneca

 

 
Deadline for Abstracts: N/A
 
Registration:

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.